Macleods Pharmaceuticals Limited is voluntarily recalling one lot of Losartan Potassium/Hydrochlorothiazide combination tablets 100mg/25mg to the consumer level due to the detection of trace amounts of an unexpected impurity (NDEA) found in finished product manufactured with active pharmaceutical ingredient made by Hetero Labs Limited. (US Food Recalls) More
Recon: Merck to Buy Peloton for $1.1B to Boost Cancer Pipeline Regulatory Focus
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. In Focus: US. Merck agrees $1bn deal to buy biopharmaceutical ...
Posted on 21 May 2019 | 2:00 am | Google News
Macleods Pharmaceuticals Limited has voluntarily recalled 1 lot of Losartan Potassium/Hydrochlorothiazide combination tablets 100mg/25mg to the consumer ...
Posted on 22 February 2019 | 3:00 am | Google News
Copyright © 2019 LastMinuteStuff.com